Disponible video en zona privada - Jornada Actualización 10/05/21
- Lee más sobre Disponible video en zona privada - Jornada Actualización 10/05/21
- Inicie sesión para enviar comentarios
Ya está disponible en el área privada el video de la 6ª Jornada Actualización Endocrinología y Diabetes.
Teprotumumab for patients with active thyroid eye disease
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
Published:April 15, 2021
DOI: https://doi.org/10.1016/S2213-8587(21)00056-5
Novedades en el manejo del síndrome de Cushing
Recent developments in the management of Cushing's syndrome
Pablo Abellán Galiana
EDITORIAL
DOI: 10.1016/j.endinu.2021.01.002
Diagnosis and treatment outcomes of Cushing’s disease during pregnancy
Pituitary (2021)
Abstract
Purpose
We report a case of a pregnant woman with Cushing’s disease (CD) and performed a systematic review of literature on diagnosis, treatment, maternal and fetal outcomes of CD in pregnancy.
Metastatic Pheochromocytomas and Abdominal Paragangliomas
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages e1937–e1952,
https://doi.org/10.1210/clinem/dgaa982
Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages 1325–1332, https://doi.org/10.1210/clinem/dgab070
Published: 09 February 2021
Abstract
Context/objective
The aim of this study was to examine the effect of statins and other lipid-lowering agents on the development of Graves orbitopathy (GO) in patients with newly diagnosed Graves disease (GD).
Methods